Quality of life in patients with symptomatic multivessel coronary artery disease: A comparative post hoc analyses of medical, angioplasty or surgical strategies-MASS II trial

Maria Elenita Corrêa de Sampaio Favarato(Universidade de São Paulo), José Antônio Franchini Ramires(Universidade de São Paulo), Aécio Flávio Teixeira de Góis(Universidade de São Paulo), José Mendes Aldrighi(Universidade de São Paulo), Whady Hueb(Universidade de São Paulo), Myrthes Emy Takiuti(Universidade de São Paulo), Célia Regina Nogueira(Universidade de São Paulo), Jorge Chiquie Borges(Universidade de São Paulo), Sérgio Almeida de Oliveira(Federal Center for Technological Education Celso Suckow da Fonseca), Neuza Lopes(Universidade de São Paulo), William E. Boden(VA New England Healthcare System), Desidério Favarato(Universidade Brasil)
International Journal of Cardiology
July 30, 2006
10.1016/j.ijcard.2006.06.001
Cited by 88

Related Papers

Transfusion Requirements After Cardiac Surgery
|JAMA|2010|1k
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials
|The Lancet|2009|746
Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data
|The Lancet|2018|733
Five-Year Follow-Up of the Medicine, Angioplasty, or Surgery Study (MASS II)
|Circulation|2007|582
Ten-Year Follow-Up Survival of the Medicine, Angioplasty, or Surgery Study (MASS II)
|Circulation|2010|322